Leonteq Securities AG’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$958K Buy
27,926
+15,559
+126% +$470K 0.03% 266
2026
Q1
$295K Buy
12,367
+9,992
+421% +$277K 0.01% 527
2025
Q4
$65.8K Sell
2,375
-2,496
-51% -$63.7K ﹤0.01% 903
2025
Q3
$118K Buy
4,871
+154
+3% +$3.06K ﹤0.01% 707
2025
Q2
$80.2K Buy
4,717
+1,607
+52% +$28K ﹤0.01% 760
2025
Q1
$60.7K Buy
3,110
+3,001
+2,753% +$78.6K ﹤0.01% 804
2024
Q4
$2.7K Sell
109
-168
-61% -$4.29K ﹤0.01% 1142
2024
Q3
$6.79K Sell
277
-6,682
-96% -$173K ﹤0.01% 1016
2024
Q2
$163K Buy
6,959
+6,105
+715% +$150K 0.01% 531
2024
Q1
$28.2K Sell
854
-152
-15% -$4.74K ﹤0.01% 873
2023
Q4
$27.4K Sell
1,006
-1,115
-53% -$27.7K ﹤0.01% 897
2023
Q3
$51K Sell
2,121
-3,496
-62% -$93.7K ﹤0.01% 797
2023
Q2
$179K Sell
5,617
-9,050
-62% -$294K 0.01% 562
2023
Q1
$449K Buy
+14,667
New +$579K 0.02% 391
2021
Q3
Sell
-100
Closed -$12.9K 1135
2021
Q2
$12.9K Sell
100
-400
-80% -$31.9K ﹤0.01% 986
2021
Q1
$40K Sell
500
-1,000
-67% -$95.1K ﹤0.01% 810
2020
Q4
$122K Buy
+1,500
New +$73.8K 0.01% 648

Other funds holding BEAM

Leonteq Securities AG's BEAM Position: Q2 2026 in Review

Leonteq Securities AG increased its Beam Therapeutics (BEAM) stake by 126% in Q2 2026, buying an estimated $470K and bringing the position to 27,926 shares worth $958K. The position accounts for 0.03% of the portfolio, ranked #266.

Leonteq Securities AG first reported a position in BEAM in Q4 2020 and has held it in 17 quarters since. 275 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Leonteq Securities AG held 27,926 shares of Beam Therapeutics worth $958K as of Q2 2026.
  • Leonteq Securities AG bought 15,559 Beam Therapeutics shares in Q2 2026, an estimated $470K.
  • Beam Therapeutics made up 0.03% of Leonteq Securities AG's portfolio in Q2 2026, its #266 holding.
  • Leonteq Securities AG first reported a position in Beam Therapeutics in Q4 2020 and has held it in 17 quarters since.
  • 275 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.